Tirzepatide is a 39-amino acid peptide that works as a dual incretin agonist, activating both GLP-1 and GIP receptors. This helps stimulate glucose-dependent insulin release, reduce glucagon levels, slow gastric emptying, and curb appetite.
Standard dosing schedule (not medical advice):
• Begin with 2.5 mg once weekly.
• Increase every 4 weeks as tolerated: 5 mg → 7.5 mg → 10 mg → up to a maximum of 15 mg weekly.
Reconstitute with 2ml of BACwater.
What the doses look like with your reconstitution:
• 2.5 mg = 50 units (typical starting dose)
• 5 mg = 100 units (full syringe)
• 7.5 mg = 150 units (usually requires two separate injections)
Start at the lowest dose (2.5 mg = 50 units weekly) and only increase gradually after several weeks if you tolerate it well. Always follow your prescriber’s guidance.